Fu N, Yang XF, Hu Y, Wu Q, Peng F. Efficacy of autologous bone marrow stem cell transplantation via the hepatic artery in combination with octreotide in the management of refractory ascites in patients with hepatic cirrhosis.
Shijie Huaren Xiaohua Zazhi 2011;
19:2376-2380. [DOI:
10.11569/wcjd.v19.i22.2376]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To evaluate the efficacy of transplantation of autologous bone marrow stem cells via the hepatic artery in combination with octreotide in the treatment of refractory ascites in patients with cirrhosis.
METHODS: Thirty-three cirrhotic patients with refractory ascites were randomly divided into two groups: treatment group (n = 14) and control group (n = 19). The treatment group underwent conventional therapy, transplantation of autologous bone marrow stem cells via the hepatic artery, and treatment with octreotide, while the control group underwent conventional therapy and treatment with octreotide. The abdominal circumference, appetite, urine volume, the status of edema of the lower extremities and ascites, serum urea nitrogen, creatinine, albumin, and health status score were compared between before and after treatment and between the two groups.
RESULTS: No obvious complications occurred in all patients. One week after treatment, the total response rate showed no significant difference between the treatment and control groups (78.57% vs 78.95%, P > 0.05). However, the total response rate at week 4 was significantly higher in the treatment group than in the control group (92.86% vs 63.16%, P < 0.05). After four weeks of treatment, the improvements in abdominal circumference and urine volume were more significant in the treatment group than in the control group (both P < 0.05), and albumin was increased from 19.79 g/L ± 4.02 g/L to 27.34 g/L ± 4.00 g/L (P < 0.05). The healthy status, as assessed according to the Karnofsky Performance Status (KPS) scale, was better in the treatment group than in the control group (P < 0.05).
CONCLUSION: Transplantation of autologous bone marrow stem cells via the hepatic artery in combination with octreotide has good short-term efficacy and safety in the management of refractory ascites in patients with cirrhosis.
Collapse